Genome Science 2024

Reveal the power of the 6-base genome – Introducing, duet multiomics solution evoC
16 July 2024
to 18 July 2024
University of Bristol, Clifton Campus, Chemistry Building
, Bristol

About the event

Are you interested in genomics and its power to revolutionise healthcare, agriculture, and our fundamental understanding of life itself?

Join biomodal at Genome Science UK 2024, the ever-popular gathering for genomics researchers, clinicians, and industry leaders in the UK. Taking place in the vibrant city of Bristol, July 16th-18th, this three-day conference offers a unique opportunity to hear from world-renowned leaders in the field such Professor Deborah Williamson (UKHSA), Prof Richard Durbin (University of Cambridge), Dr Lucy Burkitt-Grey (UK Biobank) and Prof Matt Brown (Chief Scientific Officer, Genomics England).

The conference covers the latest advancements in genomic technologies and their applications across various priority areas, including Evolving Technologies, Human & Clinical Genomics, Evolutionary Genomics, Plant and Animal Genomics, Microbes and Microbiomes, Epigenetics, Bioinformatics & Machine Learning in Genomics, Spatial and Single-Cell Genomics, and Genome Engineering. Discover the latest technologies and solutions shaping the future of genomics at our dedicated exhibitor booths.

Presenting at the event

Using the 6- base genome, genetics, 5-mC and 5-hmC, to gain multimodal insights into genome organisation and gene regulation

Dan Brudzewsky

Field Application Scientist

biomodal

16 July, 1800-1930 & 17 July 12, 1300-1400

Presentation abstract

Poster presentation

Find the venue

One sample. One workflow. One solution.

Here are the relevant biomodal resources for information. Find poster presentation information, case studies, interviews, and more.

Attending from biomodal

Aziz Mustafa
Director of Sales and Business Development, Europe

Register now

Genome Science UK 2024 16-18July

Stay up to date

Explore recent biomodal news and the events that we’ll be attending in the near future.

Cambridge Epigenetix is now biomodal